Development, Testing, Parameterization, and Calibration of a Human Physiologically Based Pharmacokinetic Model for the Plasticizer, Hexamoll® Diisononyl-Cyclohexane-1, 2-Dicarboxylate Using in Silico, in Vitro, and Human Biomonitoring Data

Frontiers in Pharmacology - Switzerland

doi 10.3389/fphar.2019.01394